Feedback / Questions
R 348 - Rigel
Rigel: Investor Day
(Rigel)
-
May 10, 2014 -
Anticipated top-line results from P2 trial for dry eye disease in H2 2014
Anticipated P2 data
•
Immunology
http://ir.rigel.com/phoenix.zhtml?p=irol-eventDetails&c=120936&eventID=5144677
May 10, 2014
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
.